|
A more recent version of this article appeared on January 1, 2005
Papers In Press, published online ahead of print October 16, 2004
J. Lipid Res., doi:10.1194/jlr.M400294-JLR200
Submitted on August 2, 2004
Revised on September 30, 2004
Accepted on October 1, 2004
Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative
Ryutaro Adachi, Yoshio Honma, Hiroyuki Masuno, Katsuyoshi Kawana, Iichiro Shimomura, Sachiko Yamada, and Makoto Makishima
Department of Biochemistry, Nihon University, Itabashi-ku, Tokyo 173-8610
Corresponding Author: maxima{at}med.nihon-u.ac.jp
The vitamin D receptor (VDR), a member of the nuclear receptor superfamily, mediates the biological actions of the active form of vitamin D, 1 ,25-dihydroxyvitamin D3 [1,25(OH)2D3]. It regulates calcium homeostasis, immunity, cellular differentiation, and other physiological processes. Recently, VDR was found to respond to bile acids as well as other nuclear receptors, farnesoid X receptor (FXR) and pregnane X receptor (PXR). The toxic bile acid lithocholic acid (LCA) induces its metabolism through VDR interaction. To elucidate structure-function relationship between VDR and bile acids, we examined the effect of several LCA derivatives on VDR activation and identified compounds with more potent activity than LCA. LCA acetate is the most potent of these VDR agonists. It binds directly to VDR and activates the receptor with 30 times the potency of LCA and has no or minimal activity on FXR and PXR. LCA acetate effectively induced the expression of VDR target genes in intestinal cells. Unlike LCA, LCA acetate inhibited the proliferation of human monoblastic leukemia cells and induced their monocytic differentiation. We propose a docking model for LCA acetate binding to VDR. The development of VDR agonists derived from bile acids should be useful to elucidate ligand-selective VDR functions.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Han and J. Y. L. Chiang
Mechanism of Vitamin D Receptor Inhibition of Cholesterol 7{alpha}-Hydroxylase Gene Transcription in Human Hepatocytes
Drug Metab. Dispos.,
March 1, 2009;
37(3):
469 - 478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Physiol Rev,
January 1, 2009;
89(1):
147 - 191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Reschly, N. Ai, S. Ekins, W. J. Welsh, L. R. Hagey, A. F. Hofmann, and M. D. Krasowski
Evolution of the bile salt nuclear receptor FXR in vertebrates
J. Lipid Res.,
July 1, 2008;
49(7):
1577 - 1587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ishizawa, M. Matsunawa, R. Adachi, S. Uno, K. Ikeda, H. Masuno, M. Shimizu, K.-i. Iwasaki, S. Yamada, and M. Makishima
Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia
J. Lipid Res.,
April 1, 2008;
49(4):
763 - 772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Inaba, K. Yamamoto, N. Yoshimoto, M. Matsunawa, S. Uno, S. Yamada, and M. Makishima
Vitamin D3 Derivatives with Adamantane or Lactone Ring Side Chains are Cell Type-Selective Vitamin D Receptor Modulators
Mol. Pharmacol.,
May 1, 2007;
71(5):
1298 - 1311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Swales, M. Korbonits, R. Carpenter, D. T. Walsh, T. D. Warner, and D. Bishop-Bailey
The farnesoid x receptor is expressed in breast cancer and regulates apoptosis and aromatase expression.
Cancer Res.,
October 15, 2006;
66(20):
10120 - 10126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Meijerman, J. H. Beijnen, and J. H.M. Schellens
Herb-Drug Interactions in Oncology: Focus on Mechanisms of Induction
Oncologist,
July 1, 2006;
11(7):
742 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Song, I. Echchgadda, Y.-K. Seo, T. Oh, S. Kim, S.-A Kim, S. Cho, L. Shi, and B. Chatterjee
An Essential Role of the CAAT/Enhancer Binding Protein-{alpha} in the Vitamin D-Induced Expression of the Human Steroid/Bile Acid-Sulfotransferase (SULT2A1)
Mol. Endocrinol.,
April 1, 2006;
20(4):
795 - 808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Ridlon, D.-J. Kang, and P. B. Hylemon
Bile salt biotransformations by human intestinal bacteria
J. Lipid Res.,
February 1, 2006;
47(2):
241 - 259.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|